Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Douglas
Clinical trial register · Australia

Clinical Trials in Douglas, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Takeda3 BeOne Medicines3 Pfizer3 Stichting Hemato-Oncologie voor Volwassenen Nederland3 Boehringer Ingelheim2
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Douglas

54 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Olivia Newton-John Cancer Research Institute
Phase 2
40
Douglas, Woolloongabba, Bedford Park, Heidelberg, Murdoch
2026-12
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Camperdown, Douglas
2026-10-01
Recruiting
BeOne Medicines
Phase 3
1,056
Blacktown, Liverpool, Wollongong, Birtinya, Douglas, Melbourne, Murdoch, Nedlands
2026-05-22
Recruiting
Takeda
Phase 3
183
Kogarah, Douglas, Greenslopes, Adelaide, St Albans, Murdoch, Melbourne
2026-01-14
Recruiting
Incyte Corporation
Phase 2
56
Darlinghurst, Douglas, Woolloongabba, Box Hill, Clayton, Melbourne
2025-12-29
Recruiting
GlaxoSmithKline
Phase 1
83
Douglas, Tugun, Geelong, Bendigo
2025-12-03
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Auchenflower, Brisbane, Brookvale, Castle Hill, Clayton, Concord, Douglas, Gosford
2025-09-06
Recruiting
Pfizer
Phase 3
714
Coffs Harbour, North Ryde, Sydney, Birtinya, Douglas, Gympie, Nambour, Woolloongabba
2025-07-23
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Recruiting
Biogen
Phase 3
180
Concord, Kogarah, Liverpool, Westmead, Douglas, Herston, Southport, Clayton
2025-05-22
Recruiting
Biogen
Phase 3
454
New Lambton, New South Wales, St Leonards, Westmead, Douglas, Herston, Southport, Woolloongabba
2025-05-08
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Adelaide, Birtinya, Brisbane, Douglas, Melbourne, Perth, Sydney
2025-05-05
Recruiting
Daiichi Sankyo
Phase 3
726
Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
2025-02-27
Active, closed
Stemline Therapeutics, Inc.
Phase 2
85
Concord, Douglas, Adelaide, Box Hill, Clayton, Fitzroy, Heidelberg, Perth
2025-01-14
Active, closed
Pfizer
Phase 3
1,035
Douglas, Woolloongabba, Capel Sound, Frankston, Melbourne, Parkville
2025-01-06
Active, closed
Vicore Pharma AB
Phase 2
378
Footscray, Adelaide, Brisbane, Concord, Darlinghurst, Douglas, Heidelberg, Sydney
2024-12-09
Active, closed
Daiichi Sankyo
Phase 3
700
Adelaide, Bedford Park, Box Hill, Concord, Darlinghurst, Douglas, Liverpool, Melbourne
2024-11-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Lismore, Westmead, Wollstonecraft, Douglas, Hervey Bay, Bedford Park, Woodville, Hobart
2024-09-18
Recruiting
The George Institute
Phase 3
2,000
Garran, Kingswood, Kogarah, New Lambton Heights, Westmead, Birtinya, Douglas, Ipswich
2024-09-04
Active, closed
Vor Biopharma
Phase 3
191
Concord, Douglas, Southport
2024-07-17
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Hobart, Nedlands, Adelaide, Clayton, Douglas, Gosford, Kogarah, Melbourne
2024-06-03
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Randwick, Prahran, Douglas, Hobart
2024-04-29
Recruiting
GlaxoSmithKline
Phase 3
864
Blacktown, Douglas, Herston, Ballarat, Geelong, Melbourne
2024-03-21
Active, closed
Pfizer
Phase 1
100
Liverpool, Waratah, Douglas, East Melbourne, Richmond
2024-02-20
Active, closed
Genmab
Phase 3
1,095
Camperdown, Liverpool, Melbourne, Westmead, Douglas, Herston, Woolloongabba, Frankston
2024-02-05
Active, closed
BicycleTx Limited
Phase 2
375
Adelaide, Brisbane, Douglas, Geelong, Hunter, Nedlands, New South Wales, South Brisbane
2024-01-24
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
DrugsBGB-43395·Elacestrant·Letrozole·Fulvestrant
BeOne Medicines
Phase 1
433
Blacktown, Bowral, Concord, North Ryde, Douglas, Adelaide, Heidelberg, Melbourne
2023-12-01
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Concord, Randwick, Douglas, Woolloongabba, Bedford Park, Hobart, Box Hill, Fitzroy
2023-09-18
Recruiting
Telethon Kids Institute
Observational
5,000
Douglas, Perth, Adelaide, Tiwi
2023-06-26
Active, closed
Exelixis
Phase 3
317
Albury, Camperdown, Liverpool, Macquarie, Sydney, Waratah, Douglas, Elizabeth Vale
2023-01-01
Recruiting
The University of Queensland
Phase 3
1,174
Gosford, Sydney, Bundaberg, Douglas, Herston, Woolloongabba, Adelaide, Melbourne
2022-11-29
Active, closed
University Medical Center Groningen
Phase 3
1,750
Canberra, New Lambton Heights, Sydney, Wollongong, Birtinya, Brisbane, Douglas, Adelaide
2022-11-08
Active, closed
Genmab
Phase 3
549
Camperdown, Kingswood, Douglas, Frankston, Murdoch, Perth
2022-09-20
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Adelaide, Birtinya, Douglas, Geelong, Melbourne, Newcastle, Sydney
2022-09-08
Recruiting
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
NCT05376267Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
University of Michigan
Not applicable
900
Brisbane, Douglas, Southport, North Adelaide, Clayton, Parkville, Nedlands
2022-08-05
Active, closed
Celgene
Phase 3
939
Birtinya, Douglas, Adelaide, Bedford Park, Clayton, East Melbourne, Melbourne, Murdoch
2022-06-23
Active, closed
BeOne Medicines
Phase 3
799
Concord, Gosford, Kogarah, Orange, Port Macquarie, Westmead, Douglas, North Adelaide
2022-03-10
Active, closed
Boehringer Ingelheim
Phase 1
151
Albury, Darlinghurst, Douglas, Heidelberg
2021-10-18
Active, closed
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481Surgical Blood Loss, Hemorrhage
Australian and New Zealand Intensive Care Research Centre
Phase 3
388
Sydney, Brisbane, Douglas, Southport, Fitzroy, Heidelberg
2021-08-17
Active, closed
Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT04969887Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm, MSI-H Solid Malignant Tumor
DrugsYervoy·Ipilimumab·Opdivo·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
240
Albury, Orange, Sydney, Waratah, Cairns, Douglas, Townsville, Adelaide
2021-08-03
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Mackay, Bedford Park, Clayton, Douglas, St Leonards, Tweed Heads, Wollongong, Woolloongabba
2021-02-23
Active, closed
AbbVie
Phase 1
21
Douglas, Hobart, Perth
2020-11-11
Recruiting
Takeda
Phase 2
160
Albury, Tweed Heads, Westmead, Douglas, Adelaide, Bedford Park, Box Hill, Geelong
2020-08-19
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Box Hill, Douglas, Heidelberg, Macquarie Park, South Australia, South Brisbane
2020-03-30
Recruiting
University of Leicester
Not applicable
2,104
Garran, Liverpool, St Leonards, Westmead, Wollongong, Chermside, Douglas, Southport
2020-03-10
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Adelaide, Brisbane, Camperdown, Douglas, Geelong, Gosford, Hobart, Melbourne
2019-12-20
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Adelaide, Brisbane, Camperdown, Canberra, Douglas, Hobart, Launceston, Melbourne
2019-03-01
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Douglas, Tugun, Adelaide, East Bentleigh, Kogarah
2018-06-21
Active, closed
Institute of Cancer Research, United Kingdom
Phase 2
345
Wagga Wagga, Brisbane, Douglas, South Brisbane, Hobart, Melbourne, Nedlands
2015-10-21
Active, closed
AstraZeneca
Phase 3
1,837
Adelaide, Auchenflower, Concord, Douglas, Gosford, Hobart, Malvern, Melbourne
2014-04-22
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Bankstown, Kingswood, Kogarah, Randwick, Waratah, Douglas, Herston, Woolloongabba
2014-04
Recruiting
Medtronic
Observational
20,000
Chermside, Douglas, Murdoch, Southport
1983-01
Rows per page Showing 1–54 of 54
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/douglas

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 54 of those studies with a site in Douglas.

How many clinical trials are recruiting in Douglas?

24 of the 54 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 28 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Douglas), 54 studies
PhaseStudiesRecruitingShare
Phase 3331461.1%
Phase 210318.5%
Phase 1529.3%
Not applicable223.7%
Observational223.7%
Phase 1/2213.7%

Most active sponsors

Lead sponsors with the most studies (Douglas)
Lead sponsorStudiesRecruiting
BeOne Medicines32
Pfizer31
Stichting Hemato-Oncologie voor Volwassenen Nederland31
Takeda33
Astellas Pharma Global Development, Inc.20
Biogen22
Boehringer Ingelheim21
Daiichi Sankyo21
Genmab20
GlaxoSmithKline22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.